Hernán Amartino

2.4k total citations
47 papers, 596 citations indexed

About

Hernán Amartino is a scholar working on Physiology, Rheumatology and Epidemiology. According to data from OpenAlex, Hernán Amartino has authored 47 papers receiving a total of 596 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Physiology, 20 papers in Rheumatology and 15 papers in Epidemiology. Recurrent topics in Hernán Amartino's work include Lysosomal Storage Disorders Research (35 papers), Glycogen Storage Diseases and Myoclonus (19 papers) and Trypanosoma species research and implications (14 papers). Hernán Amartino is often cited by papers focused on Lysosomal Storage Disorders Research (35 papers), Glycogen Storage Diseases and Myoclonus (19 papers) and Trypanosoma species research and implications (14 papers). Hernán Amartino collaborates with scholars based in Argentina, United States and Brazil. Hernán Amartino's co-authors include Christopher Lindberg, Joan Keutzer, Timothy M. Miller, Priya S. Kishnani, Amanda Wilson, Néstor Chamoles, Roberto Giugliani, Christina Lampe, Robert J. Pomponio and Patricia Vega and has published in prestigious journals such as PLoS ONE, Neurology and Gene.

In The Last Decade

Hernán Amartino

44 papers receiving 578 citations

Peers

Countries citing papers authored by Hernán Amartino

Since Specialization

Citations

This map shows the geographic impact of Hernán Amartino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hernán Amartino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hernán Amartino more than expected).

Fields of papers citing papers by Hernán Amartino

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hernán Amartino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hernán Amartino. The network helps show where Hernán Amartino may publish in the future.

Co-authorship network of co-authors of Hernán Amartino

This figure shows the co-authorship network connecting the top 25 collaborators of Hernán Amartino. A scholar is included among the top collaborators of Hernán Amartino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hernán Amartino. Hernán Amartino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genotype–phenotype findings in patients with mucopolysaccharidosis II from the Hunter Outcome Survey 2024 ·Molecular Genetics and Metabolism ·Joseph Muenzer, Hernán Amartino, Barbara K. Burton, (unknown), Anna Tylki‐Szymańska, (unknown), Jaco Botha, (unknown), David Merberg, Madhusudan Natarajan, David Whiteman, Roberto Giugliani	2
2	Evaluation of Mobilization, Apheresis, and Conditioning Regimen and Engraftment in Patients Receiving One-Time Gene Therapy with Elivaldogene Autotemcel (Eli-cel) for Cerebral Adrenoleukodystrophy (CALD) 2024 ·Transplantation and Cellular Therapy ·Christine Duncan, Paul J. Orchard, Florian Eichler, Jörn‐Sven Kühl, Satiro De Oliveira, Adrian J. Thrasher, Robert Chiesa, Jean‐Hugues Dalle, Ami J. Shah, Franco Locatelli, Nicholas Smith, Juliana Folloni Fernandes, Hernán Amartino, Caroline A. Lindemans, Jack Zhao, Ajay Singh, (unknown), Vinod K. Prasad, Andrew C. Dietz, David A. Williams	1
3	Neurodevelopmental status and adaptive behavior of pediatric patients with mucopolysaccharidosis II: a longitudinal observational study 2023 ·Orphanet Journal of Rare Diseases ·Joseph Muenzer, Barbara K. Burton, Hernán Amartino, Paul Harmatz, Luis González Gutiérrez-Solana, Matilde Ruíz-Garcìa, (unknown), David Merberg, (unknown), Simon Jones	3
4	Elivaldogene Autotemcel (eli-cel, Lenti-D) Gene Therapy for the Treatment of Cerebral Adrenoleukodystrophy: Updated Results from the Phase 2/3 ALD-102 Study and First Report on Safety Outcomes from the Phase 3 ALD-104 Study 2021 ·Transplantation and Cellular Therapy ·Paul J. Orchard, Christine Duncan, Florian Eichler, Satiro De Oliveira, Adrian J. Thrasher, Caroline Sevin, Hernán Amartino, Nicholas Smith, Jörn‐Sven Kühl, Daniel Kenney‐Jung, Robert Chiesa, Jean‐Hugues Dalle, Jing Xu, Andrew C. Dietz, Elizabeth McNeil, Patrick Aubourg, David A. Williams	2
5	Variables affecting outcomes after allogeneic hematopoietic stem cell transplant for cerebral adrenoleukodystrophy 2021 ·Blood Advances ·Robert Chiesa, Jaap Jan Boelens, Christine Duncan, Jörn‐Sven Kühl, Caroline Sevin, Neena Kapoor, Vinod K. Prasad, Caroline A. Lindemans, Simon Jones, Hernán Amartino, Mattia Algeri, Nancy Bunin, Cristina Díaz de Heredia, Daniel J. Loes, Esther Shamir, Alison Timm, Elizabeth McNeil, Andrew C. Dietz, Paul J. Orchard	19
6	Disease Stabilization Following Treatment with elivaldogene autotemcel (eli-cel, Lenti-D) Gene Therapy for the Treatment of Cerebral Adrenoleukodystrophy: Interim Results from Phase 2/3 (ALD-102) and Phase 3 (ALD-104) Studies (2064) 2021 ·Neurology ·Florian Eichler, Christine Duncan, (unknown), Satiro De Oliveira, Adrian J. Thrasher, Caroline Sevin, Hernán Amartino, Nicholas Smith, Jörn‐Sven Kühl, Patricia L. Musolino, Daniel Kenney‐Jung, Robert Chiesa, Jean‐Hugues Dalle, (unknown), Andrew C. Dietz, Elizabeth McNeil, David N. Williams	4
7	Clinical next generation sequencing in developmental and epileptic encephalopathies: Diagnostic relevance of data re-analysis and variants re-interpretation 2021 ·European Journal of Medical Genetics ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Hernán Amartino, Ignacio Sfaello, Guillermo Agosta, (unknown), (unknown), Marcelo Kauffman, Patricia Vega	14
8	The odyssey of complex neurogenetic disorders: From undetermined to positive 2020 ·American Journal of Medical Genetics Part C Seminars in Medical Genetics ·(unknown), Patricia Vega, Luca Marsili, (unknown), (unknown), (unknown), Dolores González‐Morón, (unknown), (unknown), Hernán Amartino, Clarisa Maxit, Andrea Sturchio, (unknown), (unknown), (unknown), Walter Silva, D. Consalvo, Ignacio Sfaello, Alberto J. Espay, Marcelo Kauffman	10
9	Whole exome sequencing in neurogenetic odysseys: An effective, cost- and time-saving diagnostic approach 2018 ·PLoS ONE ·Marta Córdoba, (unknown), Patricia Vega, (unknown), (unknown), Hernán Amartino, (unknown), (unknown), Dolores González‐Morón, Marcelo Kauffman	56
10	Switch from agalsidase beta to agalsidase alfa in the enzyme replacement therapy of patients with Fabry disease in Latin America. 2017 ·PubMed ·(unknown), Hernán Amartino, (unknown), (unknown), (unknown), (unknown), Rita Valdéz, (unknown), (unknown)	14
11	Effectiveness of enzyme replacement therapy in Fabry disease: Long term experience in Argentina 2017 ·Molecular Genetics and Metabolism Reports ·Gustavo Cabrera, Juan Politei, (unknown), Hernán Amartino	2
12	Practical management of behavioral problems in mucopolysaccharidoses disorders 2017 ·Molecular Genetics and Metabolism ·Maria L. Escolar, Simon Jones, Elsa Shapiro, Dafne Dain Gandelman Horovitz, Christina Lampe, Hernán Amartino	31
13	Hunter Syndrome (Mucopolysaccharidosis II) – The Signs and Symptoms a Neurologist Needs to Know 2015 ·European Neurological Review ·Hernán Amartino	4
14	Identification of 17 novel mutations in 40 Argentinean unrelated families with mucopolysaccharidosis type II (Hunter syndrome) 2014 ·Molecular Genetics and Metabolism Reports ·Hernán Amartino, (unknown), (unknown), Andreas Gal, (unknown), (unknown), (unknown), José Edgardo Dipierri, Norma Spécola, (unknown), Paula Rozenfeld	9
15	Terapia de reemplazo enzimático en la forma infantil de la enfermedad de Pompe: experiencia de un caso con 7 años de seguimiento en Argentina 2012 ·Archivos Argentinos de Pediatria ·Hernán Amartino	5
16	Molecular analysis of HEXA gene in Argentinean patients affected with Tay–Sachs disease: Possible common origin of the prevalent c.459+5A>G mutation 2012 ·Gene ·Stefania Zampieri, (unknown), Mariana Blanco, (unknown), Hernán Amartino, Kristian Vlahoviček, Marina Szlago, Andrea Schenone, (unknown), Bruno Bembi, Andrea Dardis	9
17	Fabry Disease in Latin America: Data from the Fabry Registry 2012 ·JIMD Reports ·Jacobo Villalobos, Juan Politei, Ana María Martins, Gustavo Cabrera, Hernán Amartino, Roberta Lemay, (unknown), (unknown), (unknown)	13
18	Sulthiame add‐on therapy in children with focal epilepsies associated with encephalopathy related to electrical status epilepticus during slow sleep (ESES) 2012 ·Epilepsia ·Natalio Fejerman, Roberto Caraballo, Ricardo Cersósimo, (unknown), Santiago Galicchio, Hernán Amartino	41
19	Utility of Rare Disease Registries in Latin America 2011 ·JIMD Reports ·Ana María Martins, (unknown), Adriana Linares, Juan Politei, (unknown), (unknown), (unknown), Jacobo Villalobos, Hernán Amartino, Sérgio Franco, (unknown), Roberto Giugliani, (unknown), (unknown)	2
20	Fabry Disease 2004 ·Archives of Dermatology ·Margarita Larralde, Paula Boggio, Hernán Amartino, Néstor Chamoles	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact